三友医疗
(688085)
| 流通市值：44.67亿 | | | 总市值：46.73亿 |
| 流通股本：3.51亿 | | | 总股本：3.67亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 274,020,799.16 | 123,568,286.14 | 542,792,475.29 | 391,466,199 |
| 营业收入 | 274,020,799.16 | 123,568,286.14 | 542,792,475.29 | 391,466,199 |
| 二、营业总成本 | 250,445,877.26 | 121,426,505.94 | 464,235,015.04 | 320,403,798.47 |
| 营业成本 | 68,504,488.94 | 33,631,250.89 | 136,214,752.1 | 100,558,351.55 |
| 税金及附加 | 3,023,978.07 | 1,391,374.11 | 7,261,481.48 | 5,521,173.01 |
| 销售费用 | 102,826,626.65 | 47,957,489.15 | 177,427,576.25 | 124,631,323 |
| 管理费用 | 31,922,834.19 | 15,630,297.56 | 67,686,122.71 | 42,755,710.38 |
| 研发费用 | 38,101,424.69 | 19,403,135.5 | 83,710,838.26 | 55,683,139.15 |
| 财务费用 | 6,066,524.72 | 3,412,958.73 | -8,065,755.76 | -8,745,898.62 |
| 其中:利息费用 | 897,395.35 | - | 1,288,400.96 | 1,035,913.41 |
| 其中:利息收入 | 1,886,447.08 | - | 7,306,803.25 | 5,884,750.4 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 7,521,079.4 | 4,070,914.77 | 1,100,843.27 | -931.51 |
| 加:投资收益 | -1,811,424.93 | -749,168.87 | -3,553,102.97 | -1,945,887.39 |
| 资产处置收益 | -39.38 | - | -69,045.42 | -43,284.57 |
| 资产减值损失(新) | -11,775,788.92 | -3,890,408.72 | -33,229,308.36 | -11,964,912.05 |
| 信用减值损失(新) | -1,182,459.05 | -490,762.75 | -2,067,215.57 | -2,946,423.93 |
| 其他收益 | 7,158,303.08 | 2,043,672.57 | 10,215,798.91 | 8,789,129.86 |
| 四、营业利润 | 23,484,592.1 | 3,126,027.2 | 50,955,430.11 | 62,950,090.94 |
| 加:营业外收入 | 3,000.84 | 0.17 | 4,786,154.73 | 4,916,216.59 |
| 减:营业外支出 | 21,725.96 | 20,146.8 | 537,534.45 | 203,749.23 |
| 五、利润总额 | 23,465,866.98 | 3,105,880.57 | 55,204,050.39 | 67,662,558.3 |
| 减:所得税费用 | 3,963,775.26 | 959,102.63 | 10,318,654.76 | 13,545,149.93 |
| 六、净利润 | 19,502,091.72 | 2,146,777.94 | 44,885,395.63 | 54,117,408.37 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 19,502,091.72 | 2,146,777.94 | 44,885,395.63 | 54,117,408.37 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 27,752,031.39 | 7,056,129.84 | 63,100,172.69 | 61,981,265.41 |
| 少数股东损益 | -8,249,939.67 | -4,909,351.9 | -18,214,777.06 | -7,863,857.04 |
| 扣除非经常损益后的净利润 | 14,249,623.82 | 1,495,047.53 | 48,359,817.06 | 49,355,803.43 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.08 | 0.02 | 0.19 | 0.19 |
| (二)稀释每股收益 | 0.08 | 0.02 | 0.19 | 0.19 |
| 八、其他综合收益 | 1,732,121.92 | 1,117,461.38 | -5,309,367 | -2,203,981.14 |
| 归属于母公司股东的其他综合收益 | 1,308,020.76 | 724,003.45 | -3,545,267.3 | -1,641,203.03 |
| 九、综合收益总额 | 21,234,213.64 | 3,264,239.32 | 39,576,028.63 | 51,913,427.23 |
| 归属于母公司股东的综合收益总额 | 29,060,052.15 | 7,780,133.29 | 59,554,905.39 | 60,340,062.38 |
| 归属于少数股东的综合收益总额 | -7,825,838.51 | -4,515,893.97 | -19,978,876.76 | -8,426,635.15 |
| 公告日期 | 2026-08-25 | 2026-04-28 | 2026-04-28 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |